[CYCC] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -11.66%
YoY- -11.36%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 0 0 150 0 0 0 0 -
PBT -2,090 -2,110 -2,370 -2,369 -2,354 -1,531 -2,071 0.61%
Tax -307 -268 -352 -301 -502 -182 -200 33.17%
NP -1,783 -1,842 -2,018 -2,068 -1,852 -1,349 -1,871 -3.16%
Tax Rate - - - - - - - -
Total Cost 1,783 1,842 2,168 2,068 1,852 1,349 1,871 -3.16%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 0.00 0.00 -1,345.33 0.00 0.00 0.00 0.00 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -2.07 -2.70 -2.96 -3.45 -3.09 -2.25 -3.14 -24.31%
EPS Diluted -2.07 -2.70 -2.96 -3.45 -3.09 -2.25 -3.12 -23.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.